Universal-Beteiligungs- und Servicegesellschaft
LAB icon

Universal-Beteiligungs- und Servicegesellschaft’s Standard BioTools LAB Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,454
Closed -$9.61K – 2164
2026
Q1 		$9.61K Hold
10,454
– – ﹤0.01% 2065
2025
Q4 		$13.4K Hold
10,454
– – ﹤0.01% 2049
2025
Q3 		$13.6K Buy
+10,454
New +$13.7K ﹤0.01% 2087

Other funds holding LAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's LAB Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 10,454 shares — an estimated $9.61K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in LAB in Q3 2025 and held it in 3 quarters. The position peaked at $13.6K in Q3 2025. 63 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 10,454 Standard BioTools shares in Q2 2026, an estimated $9.61K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Standard BioTools in Q3 2025 and held it in 3 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Standard BioTools position peaked at $13.6K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.